# Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion

> **NCT02860091** · — · TERMINATED · sponsor: **Boston Children's Hospital** · enrollment: 26 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Ropivacaine infusion

## Key facts

- **NCT ID:** NCT02860091
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-01
- **Primary completion:** 2026-05-14
- **Final completion:** 2026-05-14
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Sample processing no longer possible.
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02860091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02860091, "Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02860091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*